ProtoKinetix Inc (PKTX)

[drugmanrx]

Good news. bad news (but not so bad news), bad news (but not horrible news).

“These positive results in efficacy and safety in the recent testing of our AAGP® for dry eye disease is extremely promising for the future of using our molecule to treat this disease.” - said Clarence E. Smith, President and Chief Executive Officer of ProtoKinetix. “We are currently planning to move forward with the next stages of development ourselves.”

Good news - dry eye disease is extremely promising

bad news (but not so bad news) - planning to move forward with the next stages of development ourselves. Going to take MONEY, which equals dilution)

bad news (but not horrible news)- next stages of development ourselves. Doesn't appear any Big Pharma is interested at this time.

Hopefully that will change,